Bryn Mawr Trust CO Edwards Lifesciences Corp Transaction History

Bryn Mawr Trust CO

  • $5.48 Billion
  • Q3 2024

A detailed history of Bryn Mawr Trust CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bryn Mawr Trust CO holds 9,106 shares of EW stock, worth $686,410. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,106
Previous 3,686 147.04%
Holding current value
$686,410
Previous $340,000 76.47%
% of portfolio
0.01%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 25, 2024
BUY
$59.7 - $93.78 $323,574 - $508,287
5,420 Added 147.04%
9,106 $600,000
Q2 2024

Aug 08, 2024
BUY
$84.3 - $94.31 $27,566 - $30,839
327 Added 9.74%
3,686 $340,000
Q1 2024

May 14, 2024
SELL
$72.54 - $95.56 $25,751 - $33,923
-355 Reduced 9.56%
3,359 $320,000
Q3 2023

Nov 15, 2023
BUY
$69.28 - $93.38 $8,937 - $12,046
129 Added 3.6%
3,714 $257,000
Q1 2023

May 15, 2023
SELL
$74.26 - $84.51 $3,935 - $4,479
-53 Reduced 1.46%
3,585 $296,000
Q3 2022

Nov 14, 2022
BUY
$82.37 - $107.29 $4,365 - $5,686
53 Added 1.48%
3,638 $300,000
Q2 2022

Aug 11, 2022
SELL
$86.5 - $128.27 $1,124 - $1,667
-13 Reduced 0.36%
3,585 $341,000
Q1 2022

May 16, 2022
SELL
$101.96 - $128.34 $209,323 - $263,482
-2,053 Reduced 36.33%
3,598 $424,000
Q4 2021

Feb 10, 2022
SELL
$106.37 - $130.68 $229,546 - $282,007
-2,158 Reduced 27.63%
5,651 $732,000
Q3 2021

Oct 26, 2021
SELL
$102.91 - $122.75 $42,398 - $50,573
-412 Reduced 5.01%
7,809 $884,000
Q2 2021

Jul 29, 2021
SELL
$83.84 - $104.76 $4,192 - $5,238
-50 Reduced 0.6%
8,221 $852,000
Q1 2021

Apr 23, 2021
SELL
$78.68 - $90.67 $6,294 - $7,253
-80 Reduced 0.96%
8,271 $692,000
Q4 2020

Feb 11, 2021
SELL
$71.69 - $91.23 $2,867 - $3,649
-40 Reduced 0.48%
8,351 $761,000
Q3 2020

Nov 12, 2020
BUY
$67.19 - $87.44 $79,821 - $103,878
1,188 Added 16.49%
8,391 $670,000
Q2 2020

Aug 13, 2020
BUY
$57.54 - $76.95 $267,043 - $357,124
4,641 Added 181.15%
7,203 $497,000
Q1 2020

May 08, 2020
SELL
$52.41 - $81.0 $18,657 - $28,836
-356 Reduced 12.2%
2,562 $483,000
Q4 2019

Feb 11, 2020
BUY
$71.7 - $82.09 $2,724 - $3,119
38 Added 1.32%
2,918 $680,000
Q3 2019

Oct 24, 2019
SELL
$61.55 - $75.43 $7,693 - $9,428
-125 Reduced 4.16%
2,880 $634,000
Q2 2019

Aug 15, 2019
BUY
$55.74 - $64.41 $23,689 - $27,374
425 Added 16.47%
3,005 $555,000
Q1 2019

May 15, 2019
BUY
$47.89 - $64.05 $95 - $128
2 Added 0.08%
2,580 $494,000
Q3 2018

Nov 15, 2018
SELL
$45.7 - $58.03 $914 - $1,160
-20 Reduced 0.77%
2,578 $449,000
Q2 2018

Aug 14, 2018
BUY
$42.45 - $51.3 $3,905 - $4,719
92 Added 3.67%
2,598 $378,000
Q1 2018

May 15, 2018
SELL
$37.19 - $47.45 $5,206 - $6,643
-140 Reduced 5.29%
2,506 $350,000
Q4 2017

Feb 15, 2018
BUY
$33.79 - $39.39 $89,408 - $104,225
2,646
2,646 $298,000

Others Institutions Holding EW

# of Institutions
1,350
Shares Held
457M
Call Options Held
9.76M
Put Options Held
3.92M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Bryn Mawr Trust CO Portfolio

Follow Bryn Mawr Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email